Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR.
- 245 Open Clinical Trials
- 50 New Clinical Trials
- 2,068 New Patients
- 238 Principal Investigators
- 24 New Faculty Recruits
- 8 Newly Tenured Investigators
- ~300 Staff Scientists/Staff Clinicians
- ~500 Technical Lab Staff
- ~800 Postdoctoral/Clinical Fellows
- ~250 Postbaccalaureate/Predoctoral Students
- ~500 Summer Students
- >1,000 Articles in Peer-Reviewed Journals
- 46 Technology Facilities
Technology Transfer Activities
- 59 New Employee Invention Reports
- 49 Issued U.S. Patents
- 27 New Cooperative Research and Development Agreements (CRADA)
- 13 of these are Clinical CRADAs
- 184 Active CRADAs
- 83 of these are Clinical CRADAs
- 18 New Clinical Trial Agreements (CTAs)
- 74 Active CTAs
- 103 New Licenses for NCI Technologies
- 576 Active Licenses
- 4 FDA Breakthrough Drug Designations
The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices and software, and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner.
For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit(ncitechtransfer@mail.nih.gov), or visit techtransfer.cancer.gov for more information.